Session Details

SFC Session 3: Can we industrialize CAR T therapies? The practical challenges in achieving wide-spread patient access
Friday, May 29, 2020 10:45 AM - 12:15 PM 
Today the first two autologous CAR T therapies are commercialized in multiple developed countries, through dozens of health care facilities, and many hundreds of patients are benefiting from treatment! Now “industrializing” CAR T therapy to gain world-wide, broad patient access to this new standard of care, means not only extensive scale-up of manufacturing capacity but also transforming hundreds of health care centers into CAR T competent treatment sites using either autologous or “off-the-shelf” products in treating patients. What are some key considerations for how academia, industry and healthcare centers can meet this challenge? Today we’ll explore autologous, allogeneic, and stakeholder partnering perspectives from three experts active in pursuing this CAR T industrialization vision.
No Speakers Found.